FEMTOBIOMED INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,310 KRW | -3.93% |
|
-5.57% | +49.46% |
More news
| 1 day | -3.93% | ||
| 1 week | -5.57% | ||
| Current month | -7.46% | ||
| 1 month | -7.67% | ||
| 3 months | +49.73% | ||
| 6 months | +15.42% | ||
| Current year | +49.46% |
1 week
8 250.00
9 000.00
1 month
8 230.009 050.00
Current year
4 600.0010 870.00
1 year
4 600.0010 870.00
3 years
4 600.0024 900.00
5 years
4 600.0024 900.00
10 years
4 600.0024 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Hwa-Sub Choi
DFI | Director of Finance/CFO | 50 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Hyeon Lee
CEO | Chief Executive Officer | 51 | - |
Joon-Kwon Park
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Wan-Gyun Jung
BRD | Director/Board Member | 65 | - |
Femtobiomed Inc. is a Korea-based company principally work on the research and development of natural science and engineering. The Company is engaged in the development and manufacture of anticancer vaccines through its platform called CELLSHOT.
| 1st Jan change | Capi. | |
|---|---|---|
| +49.46% | 49.89M | |
| +4.09% | 43.84B | |
| +46.34% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
- Stock Market
- Equities
- A327610 Stock
